Grayzel David S.
Director at JBIO; Director at Surface Oncology, Inc.
- Sold, on record
- $31.1M
- Dollars the filings state
- Form 4 sales
- 2
- Latest Apr 9, 2024
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- JBIOJade Biosciences, Inc.Director
- Surface Oncology, Inc.Director
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Sales by company
- Surface Oncology, Inc.1.7M shares
- JBIO11,882 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Surface Oncology, Inc.UnusualDec 17, 2020 2020
Sold 1.7M shares at $18.10 ($30.8M)
Grayzel David S., Director
Sold 36.6% of holdings ($84.1M position)2.9M shares leftFirst sale on recordFiling
- 2 Form 4 sale JBIOUnusualApr 9, 2024 +1209 days
Sold 11,882 shares at $28.15 ($334k)
Grayzel David S., Director
No 10b5-1 planSold 45% of holdings ($743k position)14,502 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (2)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Apr 9, 2024 | Apr 11, 2024 | JBIO | Director | Form 4 sale | 11,882 | $334k | 45.0% | Unusual | SEC |
| Dec 17, 2020 | Dec 21, 2020 | Surface Oncology, Inc. | Director | Form 4 sale | 1.7M | $30.8M | 36.6% | Unusual | SEC |